List of Excipients in API losartan potassium and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing losartan potassium and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | HYZAAR | losartan potassium and hydrochlorothiazide | 0006-0717 | ALUMINUM OXIDE | |
| Merck Sharp & Dohme Corp | HYZAAR | losartan potassium and hydrochlorothiazide | 0006-0717 | CARNAUBA WAX | |
| Merck Sharp & Dohme Corp | HYZAAR | losartan potassium and hydrochlorothiazide | 0006-0717 | CELLULOSE, MICROCRYSTALLINE | |
| Merck Sharp & Dohme Corp | HYZAAR | losartan potassium and hydrochlorothiazide | 0006-0717 | D&C YELLOW NO. 10 | |
| Merck Sharp & Dohme Corp | HYZAAR | losartan potassium and hydrochlorothiazide | 0006-0717 | HYDROXYPROPYL CELLULOSE | |
| Merck Sharp & Dohme Corp | HYZAAR | losartan potassium and hydrochlorothiazide | 0006-0717 | HYPROMELLOSE | |
| Merck Sharp & Dohme Corp | HYZAAR | losartan potassium and hydrochlorothiazide | 0006-0717 | LACTOSE MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing losartan potassium and hydrochlorothiazide
Detailed excipient profiles for losartan potassium and hydrochlorothiazide
Excipient focus: ALUMINUM OXIDE
losartan potassium and hydrochlorothiazide drug variants containing ALUMINUM OXIDE
losartan potassium and hydrochlorothiazide drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS LACTOSE
losartan potassium and hydrochlorothiazide drug variants containing ANHYDROUS LACTOSE
losartan potassium and hydrochlorothiazide drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CARNAUBA WAX
losartan potassium and hydrochlorothiazide drug variants containing CARNAUBA WAX
losartan potassium and hydrochlorothiazide drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
losartan potassium and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
losartan potassium and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Direct Rx | losartan potassium and hydrochlorothiazide | 61919-040 |
| DIRECT RX | losartan potassium and hydrochlorothiazide | 61919-954 |
| Proficient Rx LP | losartan potassium and hydrochlorothiazide | 63187-398 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
losartan potassium and hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | losartan potassium and hydrochlorothiazide tablets | 0781-5206 |
| PD-Rx Pharmaceuticals Inc | losartan potassium and hydrochlorothiazide tablets | 43063-491 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C YELLOW NO. 10
losartan potassium and hydrochlorothiazide drug variants containing D&C YELLOW NO. 10
losartan potassium and hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
losartan potassium and hydrochlorothiazide drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | losartan potassium and hydrochlorothiazide | 0093-7367 |
| QPharma Inc | losartan potassium and hydrochlorothiazide | 42708-036 |
| A-S Medication Solutions | losartan potassium and hydrochlorothiazide | 50090-5475 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 1
losartan potassium and hydrochlorothiazide drug variants containing FD&C BLUE NO. 1
losartan potassium and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
losartan potassium and hydrochlorothiazide drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | losartan potassium and hydrochlorothiazide | 0093-7367 |
| QPharma Inc | losartan potassium and hydrochlorothiazide | 42708-036 |
| A-S Medication Solutions | losartan potassium and hydrochlorothiazide | 50090-5475 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FERRIC OXIDE YELLOW
losartan potassium and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
losartan potassium and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYPROPYL CELLULOSE
losartan potassium and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE
losartan potassium and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
losartan potassium and hydrochlorothiazide drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
losartan potassium and hydrochlorothiazide drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
losartan potassium and hydrochlorothiazide drug variants containing HYPROMELLOSE
losartan potassium and hydrochlorothiazide drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
losartan potassium and hydrochlorothiazide drug variants containing HYPROMELLOSE 2910
losartan potassium and hydrochlorothiazide drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
losartan potassium and hydrochlorothiazide drug variants containing HYPROMELLOSES
losartan potassium and hydrochlorothiazide drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
losartan potassium and hydrochlorothiazide drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | losartan potassium and hydrochlorothiazide | 33261-904 |
| LUPIN LIMITED | losartan potassium and hydrochlorothiazide | 57297-215 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
losartan potassium and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
losartan potassium and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
losartan potassium and hydrochlorothiazide drug variants containing LECITHIN, SOYBEAN
losartan potassium and hydrochlorothiazide drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
losartan potassium and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
losartan potassium and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct Rx | losartan potassium and hydrochlorothiazide | 61919-040 |
| DIRECT RX | losartan potassium and hydrochlorothiazide | 61919-954 |
| Proficient Rx LP | losartan potassium and hydrochlorothiazide | 63187-398 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
losartan potassium and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
losartan potassium and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
losartan potassium and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 3350
losartan potassium and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 4000
losartan potassium and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 4000
losartan potassium and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
losartan potassium and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | losartan potassium and hydrochlorothiazide | 29300-190 |
| Aphena Pharma Solutions - Tennessee LLC | losartan potassium and hydrochlorothiazide | 71610-671 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOLS
losartan potassium and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | losartan potassium and hydrochlorothiazide | 33261-904 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYVINYL ALCOHOL
losartan potassium and hydrochlorothiazide drug variants containing POLYVINYL ALCOHOL
losartan potassium and hydrochlorothiazide drug variants not containing POLYVINYL ALCOHOL
Excipient focus: SILICON DIOXIDE
losartan potassium and hydrochlorothiazide drug variants containing SILICON DIOXIDE
losartan potassium and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
losartan potassium and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
losartan potassium and hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
losartan potassium and hydrochlorothiazide drug variants containing STARCH, CORN
losartan potassium and hydrochlorothiazide drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
losartan potassium and hydrochlorothiazide drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | losartan potassium and hydrochlorothiazide | 13668-116 |
| LUPIN LIMITED | losartan potassium and hydrochlorothiazide | 57297-215 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: STEARIC ACID
losartan potassium and hydrochlorothiazide drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | losartan potassium and hydrochlorothiazide tablets | 0781-5206 |
| PD-Rx Pharmaceuticals Inc | losartan potassium and hydrochlorothiazide tablets | 43063-491 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing STEARIC ACID
Excipient focus: TALC
losartan potassium and hydrochlorothiazide drug variants containing TALC
losartan potassium and hydrochlorothiazide drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
losartan potassium and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
losartan potassium and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct Rx | losartan potassium and hydrochlorothiazide | 61919-040 |
| DIRECT RX | losartan potassium and hydrochlorothiazide | 61919-954 |
| Proficient Rx LP | losartan potassium and hydrochlorothiazide | 63187-398 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
losartan potassium and hydrochlorothiazide drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | losartan potassium and hydrochlorothiazide | 33261-904 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing TRIACETIN
Excipient focus: WATER
losartan potassium and hydrochlorothiazide drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | losartan potassium and hydrochlorothiazide | 33261-904 |
| >Company | >Ingredient | >NDC |
losartan potassium and hydrochlorothiazide drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
